InvestorsHub Logo
Followers 604
Posts 24107
Boards Moderated 3
Alias Born 12/06/2009

Re: bow-tie post# 11128

Thursday, 12/13/2018 9:27:21 AM

Thursday, December 13, 2018 9:27:21 AM

Post# of 27648
THEY BETTER HURRY BECAUSE... MYMX 8K STATES:

In the event that the results of the pre-clinical study program are successful, Anergis has the option to obtain an exclusive worldwide license of Mymetics’ virosome technology for the development of allergy vaccines. Should Anergis and Mymetics execute a License and Collaboration Agreement (LCA), Anergis would make an upfront payment to Mymetics in an amount that increases as the date of executing the LCA is delayed, milestone payments based on certain regulatory clearances and royalties for net sales.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News